BRIEF published on 11/18/2024 at 17:00, 1 year 9 months ago Leadership Changes at EW Healthcare Partners Private Equity Healthcare Sector Investment Strategy Leadership Changes EW Healthcare
BRIEF published on 11/18/2024 at 17:00, 1 year 9 months ago Changements de direction chez EW Healthcare Partners Stratégie D'investissement Capital-investissement Changements De Direction Secteur De La Santé EW Santé
PRESS RELEASE published on 11/18/2024 at 16:55, 1 year 9 months ago Leadership Evolution Announced by EW Healthcare Partners EW Healthcare Partners appoints Dr. Petri Vainio as Executive Chairman, Dr. Evis Hursever as CEO, Scott Barry as COO, and Marty Sutter as Founding Partner COO CEO EW Healthcare Partners Executive Chairman Founding Partner
BRIEF published on 11/18/2024 at 16:05, 1 year 9 months ago EW Healthcare Partners Unveils New Leadership Structure Growth Strategy Private Equity Leadership Change Healthcare Investment Trans-Atlantic
BRIEF published on 11/18/2024 at 16:05, 1 year 9 months ago EW Healthcare Partners dévoile sa nouvelle structure de direction Stratégie De Croissance Changement De Direction Capital-investissement Investissement Dans Le Secteur De La Santé Transatlantique
PRESS RELEASE published on 11/18/2024 at 16:00, 1 year 9 months ago EW Healthcare Partners Announces Leadership Evolution EW Healthcare Partners appoints Dr. Petri Vainio as Executive Chairman, Dr. Evis Hursever as CEO, Scott Barry as COO, and Marty Sutter as Founding Partner. Dr. Vainio to chair the Investment Committee Leadership Investments Executive Appointments EW Healthcare Partners Healthcare Private Equity
BRIEF published on 02/27/2024 at 21:00, 2 years 6 months ago Germfree élargit son Conseil d'Administration avec l'ajout de quatre membres Conseil D'administration Thérapie Cellulaire Germfree Thérapie Génique Leadership Stratégique
BRIEF published on 02/27/2024 at 21:00, 2 years 6 months ago Germfree expands its Board of Directors with the addition of four members Board Of Directors Cell Therapy Germfree Genetical Therapy Strategic Leadership
PRESS RELEASE published on 02/27/2024 at 21:00, 2 years 6 months ago Germfree Announces the Appointment of Four Independent Board Members Germfree appoints Dorothy Puhy, Karen Flynn, Kerry Ingalls, and Helga Salling as independent non-executive Board members to drive sustainable growth. Financial experts join Germfree's Board Innovation Financial Expertise Healthcare Industry Board Members Germfree
PRESS RELEASE published on 10/27/2023 at 15:00, 2 years 10 months ago EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine
Published on 09/12/2026 at 02:35, 10 hours 50 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 25 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 20 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 25 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 5 hours 55 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 10 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 15 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 40 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 10 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 17 hours ago Availability of the 2026 Interim Financial Report
